Dendritic cells and their role in atherogenesis

Area of Science:

• Immunology
• Cardiovascular Research
• Cell Biology

Background:

• Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating primary immune responses.
• DCs originate from bone marrow progenitors, migrating to peripheral tissues to monitor the microenvironment.
• Vascular-associated DCs and their role in atherosclerosis have been investigated since their identification in arteries in 1995.

Purpose of the Study:

• To explore the multifaceted role of dendritic cells in the pathogenesis of atherosclerosis.
• To understand the contribution of vascular-associated DCs to arterial homeostasis and plaque destabilization.
• To assess the potential of applying DC-based immunotherapy strategies to atherosclerosis.

Main Methods:

• Review of existing literature on dendritic cells in vascular biology and atherosclerosis.
• Analysis of studies investigating DC precursors in coronary artery disease.
• Examination of DC heterogeneity within atherosclerotic lesions.

Main Results:

• Immune reactions involving resident and monocyte-derived DCs contribute to arterial destabilization from early atherogenesis.
• Heterogeneity of DCs in atherosclerotic lesions, with some forming T cell clusters within arterial walls.
• Circulating DC precursor numbers predict coronary artery disease and atherosclerosis, indicating a role in plaque destabilization.

Conclusions:

• Dendritic cells are key players in the immune response within atherosclerotic plaques.
• DCs contribute to plaque destabilization and hold predictive value for cardiovascular disease.
• DC-based immunotherapy presents a promising avenue for treating atherosclerosis.